COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-02795-0002-0000-7
Chemical Name: Scopolamine hydrobromide trihydrate
CASRN: 6533-68-2
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 243331_CA
Study Result: Weakly Positive

Study Result: Weakly Positive
Activation Trial Trial Call
No Activation  Negative 
Induced Rat Liver S9  1_S9  Weakly Positive* 
Induced Rat Liver S9  2_S9  Weakly Positive* 

Trial #:1   Activation: No Activation    Date: 09/24/1986    Harvest Time: 12.5 hour(s)   Trial Call: Negative   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 2 0.010 1.0 0 0.000 0.0 2 0.010 1.0 0 0.000 0.0
Test Chemical: Scopolamine hydrobromide trihydrate
1000         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
1600         
200 2 0.010 1.0 0 0.000 0.0 2 0.010 1.0 0 0.000 0.0
3000         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
Positive Control: Mitomycin-C
 0.0625    
200 40 0.200 16.0 16 0.080 6.0 24 0.120 11.0 0 0.000 0.0
Mitomycin-C
 0.25      
50 17 0.340 30.0 13 0.260 22.0 4 0.080 8.0 0 0.000 0.0
Trend: -0.398 0.000 -0.398  
Probability: 0.655 0.000 0.655  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 01/19/1988    Harvest Time: 13 hour(s)   Trial Call: Weakly Positive*   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 1 0.005 0.5 0 0.000 0.0 1 0.005 0.5 0 0.000 0.0
Test Chemical: Scopolamine hydrobromide trihydrate
1600         
200 3 0.015 1.5 1 0.005 0.5 2 0.010 1.0 0 0.000 0.0
3000         
200 2 0.010 1.0 0 0.000 0.0 2 0.010 1.0 0 0.000 0.0
5000         
200 28 0.140 11.0 2 0.010 1.0 26 0.130 10.5 0 0.000 0.0
Positive Control: Cyclophosphamide
2.5       
200 28 0.140 12.0 3 0.015 1.5 25 0.125 11.0 0 0.000 0.0
Cyclophosphamide
7.5       
50 17 0.340 34.0 3 0.060 6.0 14 0.280 28.0 0 0.000 0.0
Trend: 5.188 1.240 5.209  
Probability: 0.000 0.108 0.000  


Trial #:2_S9   Activation: Induced Rat Liver S9    Date: 10/21/1986    Harvest Time: 13.5 hour(s)   Trial Call: Weakly Positive*   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0 0 0.000 0.0
Test Chemical: Scopolamine hydrobromide trihydrate
1600         
200 3 0.015 1.5 0 0.000 0.0 3 0.015 1.5 0 0.000 0.0
3000         
200 2 0.010 1.0 1 0.005 0.5 1 0.005 0.5 0 0.000 0.0
5000         
200 12 0.060 6.0 1 0.005 0.5 11 0.055 5.5 0 0.000 0.0
Positive Control: Cyclophosphamide
2.5       
200 35 0.175 15.0 7 0.035 3.0 28 0.140 12.5 0 0.000 0.0
Cyclophosphamide
7.5       
50 23 0.460 36.0 8 0.160 14.0 15 0.300 26.0 0 0.000 0.0
Trend: 3.320 0.269 3.508  
Probability: 0.000 0.394 0.000